SCHEMBL7192113

SCHEMBL7192113

CC(C)(C#N)c1ccc(CCCCCl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.41
ESR1 P03372 3/20 0.37
ESR2 Q92731 2/20 0.37
RORC P51449 1/20 0.36
HSD17B10 Q99714 2/20 0.36
TSHR P16473 1/20 0.36
SIGMAR1 Q99720 5/20 0.34
PTPN2 P17706 1/20 0.34
PTPN1 P18031 1/20 0.34
PTPN6 P29350 1/20 0.34
PTPN11 Q06124 1/20 0.34
AXL P30530 1/20 0.33
MTOR P42345 1/20 0.32
THRA P10827 1/20 0.32
THRB P10828 1/20 0.32
LMNA P02545 2/20 0.31
CYP19A1 P11511 1/20 0.31
UGT1A4 P22310 1/20 0.31
PDE4D Q08499 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11424007 0.87 KCNH2 (0.43) KCNH2ESR1ESR2RORCHSD17B10
SCHEMBL17023799 0.80 KCNH2 (0.61) KCNH2TSHRSIGMAR1LMNA
SCHEMBL27611577 0.79 KCNH2 (0.38) KCNH2ESR1ESR2RORCHSD17B10
SCHEMBL19980692 0.78 RORC (0.43) ESR1ESR2RORCHSD17B10TSHR
SCHEMBL25920006 0.77 KCNH2 (0.36) KCNH2ESR1ESR2RORCHSD17B10
SCHEMBL3942362 0.77 TAAR1 (0.52) ESR1ESR2RORCKMT2AKDM4E
SCHEMBL19972655 0.77 CA2 (0.43) ESR1ESR2RORCTSHRMTOR
SCHEMBL8763390 0.75 ESR1 (0.44) ESR1ESR2RORCTSHRAXL
Hydrochloric Acid SCHEMBL3943536 0.75 TAAR1 (0.50) ESR1ESR2KMT2AKDM4EALDH1A1
SCHEMBL9135033 0.74 MAOB (0.44) ESR1HSD17B10TSHRSIGMAR1THRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6552200-B2 Antiallergens MERRELL PHARMACEUTICALS INC. 2003-04-22 US disclosed
US-20010020114-A1 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives MERRELL PHARMACEUTICALS INC. 2001-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010020114-A1 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives HRH1, HRH3, HRH4 KCNH2 454/4885ESR1 4110/4885ESR2 2708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.